|Peter Y Matlock: experienced Life Science executive and entrepreneur with proven track record in:
Start-up formation and management;
Critical problem solving and implementation;
Commercializing research technology;
Building relationships among corporations, academic institutions
Intellectual property management;
Quantitative analysis; and
Strategy and policy development.
Founder and President of cutting-edge Biotechnology companies in molecular farming (Ventria Biosciences), biocatalysis/green chemistry (Viridis) and rational directed evolution of therapeutic antibodies (Bioren--acquired by Pfizer). Business development in all major applications of Biotechnology, turn-around experience, licensing at Stanford University and Lawrence Livermore's Human Genome Center.